Machine Learning Approach for Cardiovascular Death Prediction among Nonalcoholic Steatohepatitis (NASH) Liver Transplant Recipients

被引:0
|
作者
Fatemi, Yasin [1 ]
Nikfar, Mohsen [1 ]
Oladazimi, Amir [1 ]
Zheng, Jingyi [2 ]
Hoy, Haley [3 ]
Ali, Haneen [1 ,4 ]
机构
[1] Auburn Univ, Dept Ind & Syst Engn, Auburn, AL 36849 USA
[2] Auburn Univ, Dept Math & Stat, Auburn, AL 36849 USA
[3] Univ Alabama Huntsville, Coll Nursing, Huntsville, AL 35805 USA
[4] Auburn Univ, Hlth Serv Adm Program, Auburn, AL 36849 USA
关键词
liver transplant; NASH; cardiovascular; machine learning; UNOS; ABO BLOOD-GROUP; BODY-MASS INDEX; ABDOMINAL OBESITY; KIDNEY-DISEASE; RISK; EVENTS; ASSOCIATION; FAILURE; LIMITATIONS; CARDIORISK;
D O I
10.3390/healthcare12121165
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Cardiovascular disease is the leading cause of mortality among nonalcoholic steatohepatitis (NASH) patients who undergo liver transplants. In the present study, machine learning algorithms were used to identify important risk factors for cardiovascular death and to develop a prediction model. The Standard Transplant Analysis and Research data were gathered from the Organ Procurement and Transplantation Network. After cleaning and preprocessing, the dataset comprised 10,871 patients and 92 features. Recursive feature elimination (RFE) and select from model (SFM) were applied to select relevant features from the dataset and avoid overfitting. Multiple machine learning algorithms, including logistic regression, random forest, decision tree, and XGBoost, were used with RFE and SFM. Additionally, prediction models were developed using a support vector machine, Gaussian na & iuml;ve Bayes, K-nearest neighbors, random forest, and XGBoost algorithms. Finally, SHapley Additive exPlanations (SHAP) were used to increase interpretability. The findings showed that the best feature selection method was RFE with a random forest estimator, and the most critical features were recipient and donor blood type, body mass index, recipient and donor state of residence, serum creatinine, and year of transplantation. Furthermore, among all the outcomes, the XGBoost model had the highest performance, with an accuracy value of 0.6909 and an area under the curve value of 0.86. The findings also revealed a predictive relationship between features and cardiovascular death after liver transplant among NASH patients. These insights may assist clinical decision-makers in devising strategies to prevent cardiovascular complications in post-liver transplant NASH patients.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] The Trend of Nonalcoholic Steatohepatitis (NASH) among Adults awaiting Liver Transplantation in the United States over the Next Decade
    Hajifathalian, Kaveh
    Hanouneh, Ibrahim
    McCullough, Arthur J.
    HEPATOLOGY, 2016, 64 : 572A - 572A
  • [42] Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity
    Duchini, A
    Brunson, ME
    TRANSPLANTATION, 2001, 72 (01) : 156 - 159
  • [43] Population Pharmacokinetic Modeling Combined With Machine Learning Approach Improved Tacrolimus Trough Concentration Prediction in Chinese Adult Liver Transplant Recipients
    Li, Zi-ran
    Li, Rui-dong
    Niu, Wan-jie
    Zheng, Xin-yi
    Wang, Zheng-xin
    Zhong, Ming-kang
    Qiu, Xiao-yan
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (03): : 314 - 325
  • [44] A MACHINE LEARNING MODEL BASED ON LIVER HISTOLOGY PREDICTS THE HEPATIC VENOUS PRESSURE GRADIENT (HVPG) IN PATIENTS WITH COMPENSATED CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH)
    Bosch, Jaime
    Harrison, Stephen A.
    Abdelmalek, Manal F.
    Shiffman, Mitchell L.
    Rockey, Don C.
    Juyal, Dinkar
    Shanis, Zahil
    Pokkalla, Harsha
    Shukla, Chinmay
    Carrasco-Zevallos, Oscar
    Resnick, Murray
    Montalto, Michael
    Beck, Andrew
    Wapinski, Ilan
    Jia, Catherine
    Chung, Chuhan
    Myers, Robert P.
    Goodman, Zachary D.
    Afdhal, Nezam H.
    Sanyal, Arun J.
    HEPATOLOGY, 2020, 72 : 887A - 888A
  • [45] Mortality Prediction In Heart Transplant Recipients Using Machine Learning Methods
    Carcamo, Francisco javier jimenez
    Rubens, Muni
    Saxena, Anshul
    Koerfer, Daniel
    Gonzalez, Pablo gordilo
    Ali, Shozab
    Vaidean, Georgetta
    Chaparro, Sandra
    Fontana, Marianna
    Kumar, Varun
    Sheridan, Paige
    Rubens, Lexie
    Toyip, Astra
    Boehme, Amelia
    Bender, Shaun
    Capocelli, Kelley
    Danese, David
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (01)
  • [46] THE RELATIONSHIP BETWEEN SERUM ATHEROGENIC RISK AND NONALCOHOLIC FATTY LIVER DISEASE AMONG LIVER TRANSPLANT RECIPIENTS
    Garg, Shreya
    Baral, Alok
    Ang, Audrey
    Nguyen, Madison
    Razzaq, Rehan
    Arshad, Tamoore
    Khan, Hiba
    O'Connor, Ian
    Elmahdi, Siddiq
    Tseng, Michael
    Patel, Vaishali
    Connelly, Margery
    Siddiqui, Mohammad S.
    HEPATOLOGY, 2023, 78 : S348 - S349
  • [47] A Machine Learning Approach for Prediction of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients.
    Kawakita, S.
    Waterman, A.
    Everly, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 784 - 784
  • [48] Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis
    Noureddin, Mazen
    Goodman, Zachary
    Tai, Dean
    Chng, Elaine L. K.
    Ren, Yayun
    Boudes, Pol
    Shlevin, Harold
    Garcia-Tsao, Guadalupe
    Harrison, Stephen A.
    Chalasani, Naga P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (04) : 409 - 417
  • [49] POST LIVER TRANSPLANT SURVIVAL AMONG HISPANIC AND NON-HISPANIC WHITE PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH): AN ORGAN PROCUREMENT AND TRANSPLANTATION NETWORK (OPTN) ANALYSIS
    Shah, Pankil
    Noureddin, Mazen
    Alkhouri, Naim
    HEPATOLOGY, 2023, 78 : S1028 - S1030
  • [50] Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain
    Romero-Gomez, Manuel
    Kachru, Nandita
    Zamorano, Meritxell Ascanio
    Darba, Josep
    Shreay, Sanatan
    MEDICINE, 2020, 99 (50) : E23506